Together to Build Resistance
What is AMR?
Antimicrobial Resistance, or AMR, refers to the phenomena by which bacteria become immune to antimicrobial treatments over time as those treatments are used more and more. Infectious diseases brought on by antimicrobial resistant bacteria can be difficult to treat, and can even be fatal in worst case scenarios.
The problem of AMR is worsening across the world. If current trends continue, it is estimated that by 2050, as many as 10 million people could potentially die of AMR-related causes globally every year.
What is AMR Alliance Japan?
What is AMR Alliance Japan?
AMR Alliance Japan is a collaboration between Japanese medical societies specializing in infectious diseases, corporations working to develop tests and treatments for those diseases, and civil society groups. Since its establishment in November 2018, AMR Alliance Japan has worked with Alliance members and partner organizations to deepen policy debate around AMR. This work resulted in the July 2019 release of "AMR Alliance Japan Policy Recommendations: The Japanese Government’s Role in Promoting AMR Countermeasures." Moving forward, the Alliance will take every opportunity to explain these recommendations to AMR policy stakeholders toward concrete policy action on AMR.
Our Policy Recommendations
AMR Alliance Japan aims to function as a one-stop shop for information on all activities going on in Japan around AMR, in order to facilitate greater collaboration and information sharing among stakeholders.
- 01 - Promoting antimicrobial stewardship based on the actual situation at healthcare facilities
- 02 - Constructing domestic AMR surveillance and crisis management systems
- 03 - Enabling the further and active use of AMR screening methods and rapid diagnostic technology
- 04 - Supporting education on AMR for the public and medical practitioners
- 05 - Establishing incentive models to encourage R&D for antimicrobials
- 06 - Stabilizing the supply of antimicrobials
- 07 - International collaborations to share case studies and lessons learned on AMR domestically and abroad
Shionogi & Co., Ltd.
Shiro Shoni Iryo Mamoro Kodomo-tachi no Kai*
The Japanese Society for Medical Mycology
Japanese Society of Pharmaceutical Health Care and Sciences
Japanese Society of Chemotherapy
Japanese Society for Infection Prevention and Control
The Japanese Association for Infectious Diseases
Japanese Society for Pediatric Infectious Diseases*
Japan Pharmaceutical Manufacturers Association
The Japanese Society of Therapeutic Drug Monitoring*
Nippon Becton, Dickinson and Company, Ltd.*
The Pharmaceutical Society of Japan
The Japanese Society for Clinical Microbiology*
Pfizer Japan Inc.*
- *These banners are linked to Japanese
Health and Global Policy Institute